SCHEMBL15066792

SCHEMBL15066792

CC1Nc2cc3ccc(Br)cc3cc2C1(C)C

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.36
CYP2A6 P11509 1/20 0.36
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
PGR P06401 3/20 0.32
HTR2B P41595 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
ADRA2A P08913 1/20 0.31
PNMT P11086 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539867 0.82 AR (0.38) ARMEN1MAPTKMT2APGR
SCHEMBL650304 0.74 SIRT2 (0.39) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL11326119 0.67 AR (0.39) ARKDM4EALDH1A1MAPTPGR
SCHEMBL8657926 0.67 RARA (0.49) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL7092850 0.66 SNCA (0.43) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL8404534 0.65 CYP2A6 (0.56) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL24725924 0.65 MRGPRX2 (0.40) ARSIGMAR1
SCHEMBL30625888 0.65 AR (0.38) ARSIGMAR1
SCHEMBL9358413 0.65 PGR (0.42) ARKDM4EMEN1ALDH1A1KMT2A
SCHEMBL17849092 0.64 CYP2A6 (0.68) CYP2A6KDM4EMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4749267-A2 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION University of Washington Through Its Center for Commercialization (US) 2026-05-27 EP disclosed
EP-3718573-B1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2026-05-20 EP disclosed
US-20240254288-A1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2024-08-01 US disclosed
US-11697713-B2 Chromophoric polymer dots with narrow-band emission UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2023-07-11 US disclosed
EP-3718573-A1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION University of Washington Through Its Center for Commercialization (US) 2020-10-07 EP disclosed
US-20190106542-A1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION 2019-04-11 US disclosed
US-20190106542-A1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION 2019-04-11 US disclosed
US-10150841-B2 Chromophoric polymer dots with narrow-band emission UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2018-12-11 US disclosed
US-20140350183-A1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION 2014-11-27 US disclosed
US-20140350183-A1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION 2014-11-27 US disclosed
EP-2797635-A2 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION University of Washington Through Its Center for Commercialization (US) 2014-11-05 EP disclosed
WO-2013101902-A2 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION UNIVERSITY OF WASHINGTON, THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2013-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190106542-A1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION CDYL, PCBP1, CACYBP AR 4152/4885CYP2A6 2171/4885KDM4E 3095/4885
US-20240254288-A1 CHROMOPHORIC POLYMER DOTS WITH NARROW-BAND EMISSION CDYL, PCBP1, CACYBP AR 4152/4885CYP2A6 2171/4885KDM4E 3095/4885
US-11697713-B2 Chromophoric polymer dots with narrow-band emission CDYL, PCBP1, CACYBP AR 4152/4885CYP2A6 2171/4885KDM4E 3095/4885
US-10150841-B2 Chromophoric polymer dots with narrow-band emission CDYL, PCBP1, CACYBP AR 4152/4885CYP2A6 2171/4885KDM4E 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.